Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Nicotinamide riboside has minimal impact on energy metabolism in mouse models of mild obesity
David M. Cartwright, Lucy Oakey, Rachel S. Fletcher, et al.
Journal of Endocrinology (2021) Vol. 251, Iss. 1, pp. 111-123
Open Access | Times Cited: 13

Showing 13 citing articles:

Balancing NAD+ deficits with nicotinamide riboside: therapeutic possibilities and limitations
Angelique Cercillieux, Eleonora Ciarlo, Carles Cantó
Cellular and Molecular Life Sciences (2022) Vol. 79, Iss. 8
Open Access | Times Cited: 30
Targeting epigenetics: A novel promise for Alzheimer’s disease treatment
Danko Jeremic, Lydia Jiménez‐Díaz, Juan D. Navarro‐López
Ageing Research Reviews (2023) Vol. 90, pp. 102003-102003
Closed Access | Times Cited: 18
Modulating Sirtuin Biology and Nicotinamide Adenine Diphosphate Metabolism in Cardiovascular Disease—From Bench to Bedside
Yu-Jen Wang, Francesco Paneni, Sokrates Stein, et al.
Frontiers in Physiology (2021) Vol. 12
Open Access | Times Cited: 34
Nicotinamide Adenine Dinucleotide in Aging Biology: Potential Applications and Many Unknowns
Shalender Bhasin, Douglas R. Seals, Marie E. Migaud, et al.
Endocrine Reviews (2023) Vol. 44, Iss. 6, pp. 1047-1073
Open Access | Times Cited: 15
Nicotinamide Riboside, a Promising Vitamin B3 Derivative for Healthy Aging and Longevity: Current Research and Perspectives
Andrei Biţă, Ion Romulus Scorei, Maria Viorica Ciocîlteu, et al.
Molecules (2023) Vol. 28, Iss. 16, pp. 6078-6078
Open Access | Times Cited: 14
Improvement in Mung Bean Peptide on High-Fat Diet-Induced Insulin Resistance Mice Using Untargeted Serum Metabolomics
Lina Li, Yu Tian, Yuchao Feng, et al.
Frontiers in Nutrition (2022) Vol. 9
Open Access | Times Cited: 17
Sirtuin 3 Dependent and Independent Effects of NAD+ to Suppress Vascular Inflammation and Improve Endothelial Function in Mice
Xiaoyun Cao, Yalan Wu, Huiling Hong, et al.
Antioxidants (2022) Vol. 11, Iss. 4, pp. 706-706
Open Access | Times Cited: 9
NAD+ Therapeutics and Skeletal Muscle Adaptation to Exercise in Humans
Dean G. Campelj, Andrew Philp
Sports Medicine (2022) Vol. 52, Iss. S1, pp. 91-99
Open Access | Times Cited: 6
Dietary supplementation with nicotinamide riboside improves fetal growth under hypoglycemia
Sang R. Lee, Su Hee Jeong, Moeka Mukae, et al.
The Journal of Nutritional Biochemistry (2023) Vol. 116, pp. 109310-109310
Open Access | Times Cited: 2
Sex-specific effects of CD248 on metabolism and the adipose tissue lipidome
Kieran Patrick, Xiang Tian, David Cartwright, et al.
PLoS ONE (2023) Vol. 18, Iss. 4, pp. e0284012-e0284012
Open Access | Times Cited: 2
Harnessing NAD+ Metabolism as Therapy for Cardiometabolic Diseases
Akash Deep Chakraborty, Keaton E. Minor, Hina Lateef Nizami, et al.
Current Heart Failure Reports (2022) Vol. 19, Iss. 4, pp. 157-169
Open Access | Times Cited: 2
Nutraceuticals for targeting NAD+ to restore mitochondrial function
Antje Garten, Gareth G. Lavery
Elsevier eBooks (2022), pp. 433-460
Closed Access
Page 1

Scroll to top